Skip navigation
Skip navigation

Browsing by Author Jackson, Ronald

Or enter first few letters:  
Showing results 9 to 15 of 15

Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy

Author(s)Jackson, Ronald; Worley, Matthew; Trivedi, Shubhanshi, et al
TypeJournal article
Date Published2014
Date Created-

Progresses in DNA-based heterologous prime-boost immunization strategies

Author(s)Jackson, Ronald; Boyle, David B; Ranasinghe, Charani
TypeBook chapter
Date Published2014
Date Created-

Role of novel type i interferon epsilon in viral infection and mucosal immunity

Author(s)Xi, Yang; Day, Stephanie; Jackson, Ronald, et al
TypeJournal article
Date Published2012
Date Created-

The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4

Author(s)Robbins, S; Jackson, Ronald; Fenner, Frank, et al
TypeJournal article
Date Published2005
Date Created-

The mousepox experience: An interview with Ronald Jackson and Ian Ramshaw on dual-use research

Author(s)Selgelid, Michael; Weir, Lorna; Jackson, Ronald, et al
TypeJournal article
Date Published2010
Date Created-

Unique IL-13Ralpha2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8 รพ T-cell avidity and protective immunity

Author(s)Trivedi, Shubhanshi; Stambas, John; Jackson, Ronald, et al
TypeJournal article
Date Published2013
Date Created-
1-s2.0-S0264410X19301215-main.pdf.jpg

Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes

Author(s)Roy, Sreeja; Jaeson, Irwan; Li, Jerry, et al
TypeJournal article
Date Published2019
Date Created-

Updated:  12 April 2016/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator